Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy

被引：0

作者：

Cristina Chiriaco

Chiara Donini

Marco Cortese

Stefano Ughetto

Chiara Modica

Ilaria Martinelli

Alessia Proment

Letizia Vitali

Lara Fontani

Monica Casucci

Paolo Maria Comoglio

Silvia Giordano

Dario Sangiolo

Valeria Leuci

Elisa Vigna

机构：

[1] Candiolo Cancer Institute,Department of Oncology

[2] FPO-IRCCS,Present address: Department of Surgical, Oncological and Stomatological Sciences (DICHIRONS)

[3] University of Turin,Innovative Immunotherapies Unit

[4] Present address: Bios-Therapy,undefined

[5] Physiological System for Health S.p.A,undefined

[6] University of Palermo,undefined

[7] IRCCS San Raffaele Scientific Institute,undefined

[8] IFOM-FIRC Institute of Molecular Oncology,undefined

来源：

Journal of Experimental & Clinical Cancer Research | / 41卷

关键词：

MET oncogene; Immunotherapy; CAR; Targeted therapy; Gastric cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] TUMOR TARGETED SUPERANTIGEN (TTS), NAPTUMOMAB ESTAFENATOX (NAP), ENHANCES CAR-T CELLS POTENCY AND CAN BOOST CAR-T EFFICACY AGAINST SOLID TUMORS
Sagi, Yael
Shahar, Michal
Pinsker, Marina
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A605 - A605
[42] CAR-T Cell Therapy: the Efficacy and Toxicity Balance
Chohan, Karan L.
Siegler, Elizabeth L.
Kenderian, Saad S.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (02) : 9 - 18
[43] Binding and Efficacy of Anti-Robo4 CAR-T Cells against Solid Tumors
Hirobe, Sachiko
Nagai, Seina
Tachibana, Masashi
Okada, Naoki
BIOMEDICINES, 2022, 10 (06)
[44] Efficacy and safety of CAR-T cell therapy in minorities
Thakkar, Astha
Abreu, Michelly
Pradhan, Kith
Sica, R. Alejandro
Shastri, Aditi
Kornblum, Noah
Shah, Nishi
Mantzaris, Ioannis
Gritsman, Kira
Feldman, Eric
Elkind, Richard
Green-Lorenzen, Susan
Verma, Amit
Braunschweig, Ira
Goldfinger, Mendel
BONE MARROW TRANSPLANTATION, 2022, 57 (07) : 1187 - 1190
[45] Efficacy and safety of CAR-T cell therapy in minorities
Astha Thakkar
Michelly Abreu
Kith Pradhan
R. Alejandro Sica
Aditi Shastri
Noah Kornblum
Nishi Shah
Ioannis Mantzaris
Kira Gritsman
Eric Feldman
Richard Elkind
Susan Green-Lorenzen
Amit Verma
Ira Braunschweig
Mendel Goldfinger
Bone Marrow Transplantation, 2022, 57 : 1187 - 1190
[46] CAR-T Cell Therapy: the Efficacy and Toxicity Balance
Karan L. Chohan
Elizabeth L. Siegler
Saad S. Kenderian
Current Hematologic Malignancy Reports, 2023, 18 : 9 - 18
[47] Safety and Efficacy of BCMA-Targeted CAR-T Therapy in Geriatric Patients with Multiple Myeloma
Reyes, Kevin R.
Huang, Chiung-Yu
Lo, Mimi
Arora, Shagun
Chung, Alfred
Wong, Sandy W.
Wolf, Jeffrey L.
Martin, Thomas
Shah, Nina
Banerjee, Rahul
BLOOD, 2022, 140 : 5105 - 5107
[48] Efficacy and safety of BCMA-targeted CAR-T therapy in elderly patients with multiple myeloma
Reyes, Kevin
Huang, Chiung-Yu
Lo, Mimi
Arora, Shagun
Chung, Alfred
Wong, Sandy
Wolf, Jeffrey
Martin, Thomas
Shah, Nina
Banerjee, Rahul
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S5 - S5
[49] Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer
Jiannan Chen
Jianhua Hu
Lili Gu
Feng Ji
Fan Zhang
Miaomiao Zhang
Jun Li
Zhengliang Chen
Longwei Jiang
Yan Zhang
Ruifang Shi
Lihua Ma
Shaochang Jia
Ying Zhang
Qi Zhang
Junqing Liang
Shunyu Yao
Zhigang Hu
Zhigang Guo
Cancer Immunology, Immunotherapy, 2023, 72 : 409 - 425
[50] Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer
Chen, Jiannan
Hu, Jianhua
Gu, Lili
Ji, Feng
Zhang, Fan
Zhang, Miaomiao
Li, Jun
Chen, Zhengliang
Jiang, Longwei
Zhang, Yan
Shi, Ruifang
Ma, Lihua
Jia, Shaochang
Zhang, Ying
Zhang, Qi
Liang, Junqing
Yao, Shunyu
Hu, Zhigang
Guo, Zhigang
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (02) : 409 - 425

← 1 2 3 4 5 →